前收市價 | 26.34 |
開市 | 26.76 |
買盤 | 26.43 x 100 |
賣出價 | 26.61 x 200 |
今日波幅 | 25.69 - 27.02 |
52 週波幅 | 13.36 - 27.50 |
成交量 | |
平均成交量 | 360,767 |
市值 | 726.128M |
Beta 值 (5 年,每月) | -0.29 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -6.08 |
業績公佈日 | 2024年5月09日 - 2024年5月13日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 45.44 |
AnaptysBio (ANAB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AnaptysBio (ANAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
The stock market may have pulled back a bit from the all-time high reached late last month but the S&P 500 remains 7.4% higher in 2024. Technology stocks continue to be top performers with Super Micro Computer (NASDAQ:SMCI) leading the way with a 216% gain so far. However, analysts at the wealth management arm of Goldman Sachs think the tech sector may have run its course. They say it is time to start looking elsewhere. Investors would be better off taking the profits they’ve made in tech and de